It is apparent from the analysis described here that heparanase is not a straight-forward anti-cancer drug target despite the wealth of evidence to indicate it contributes to tumor growth, tumor cell migration, metastasis formation, and chemoresistance. This evidence concerns the gene HPSE and cancer.